High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany

被引:27
|
作者
Reinert, RR [1 ]
Lütticken, R [1 ]
Al-Lahham, A [1 ]
机构
[1] Univ Hosp, Natl Reference Ctr Streptococci, Inst Med Microbiol, D-52057 Aachen, Germany
关键词
Emm typing; fluoroquinolone resistance; multilocus sequence typing; resistance; Streptococcus pyogenes;
D O I
10.1111/j.1469-0691.2004.00890.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An isolate of Streptococcus pyogenes isolated from a 63-year-old woman with a serious wound infection was found to be highly resistant to fluoroquinolones (levofloxacin MIC greater than or equal to 32 mg/L). DNA amplification and sequencing revealed a serine-81 to phenylalanine substitution in gyrA and three substitutions in parC: serine-79 to phenylalanine, aspartic acid-91 to asparagine, and serine-140 to proline. To our knowledge, this is the first report from a European country of a clinical isolate of S. pyogenes with high-level fluoroquinolone resistance.
引用
收藏
页码:659 / 662
页数:5
相关论文
共 50 条
  • [31] In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease
    Pérez-Trallero, E
    Marimón, JM
    González, A
    Ercibengoa, M
    Larruskain, J
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (04) : 560 - 564
  • [32] Overproduction of a metallo-β-lactamase by a strong promoter causes high-level imipenem resistance in a clinical isolate of Pseudomonas aeruginosa
    Takeda, Shinobu
    Nakai, Toru
    Ikeda, Fumiaki
    Hatano, Kazuo
    CHEMOTHERAPY, 2008, 54 (03) : 181 - 187
  • [33] High-level ivermectin resistance in a field isolate of Haemonchus contortus associated with a low level of resistance in the larval stage:: implications for resistance detection
    Kotze, AC
    Dobson, RJ
    Tyrrell, KL
    Stein, PA
    VETERINARY PARASITOLOGY, 2002, 108 (03) : 255 - 263
  • [34] Distribution of high-level mupirocin resistance among clinical MRSA
    Hosseini, Hamideh Mahmoodzadeh
    Kiyani, Nasibeh
    Amin, Mohsen
    Ch, Mojtaba Hedayati
    Fooladi, Abbas Ali Imani
    JOURNAL OF CHEMOTHERAPY, 2017, 29 (04) : 215 - 219
  • [35] Heterogeneity of resistance elements in clinical isolates of enterococci with high-level gentamicin resistance
    Teng, LJ
    Liaw, SJ
    Hsueh, PR
    Ho, SW
    Luh, KT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (12) : 855 - 859
  • [36] Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS
    Lucas, Deanna Deveson
    Crane, Bethany
    Wright, Amy
    Han, Mei-Ling
    Moffatt, Jennifer
    Bulach, Dieter
    Gladman, Simon L.
    Powell, David
    Aranda, Jesus
    Seemann, Torsten
    Machado, Diana
    Pacheco, Teresa
    Marques, Teresa
    Viveiros, Miguel
    Nation, Roger
    Li, Jian
    Harper, Marina
    Boyce, John D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (07)
  • [37] Plasmid-mediated high-level ceftriaxone resistance in a Salmonella enterica serotype typhimurium isolate
    Dimitrov, TS
    Udo, EE
    Verghese, T
    Emara, M
    Al-Saleh, A
    MEDICAL PRINCIPLES AND PRACTICE, 2006, 15 (02) : 145 - 148
  • [38] HIGH-LEVEL QUINOLONE RESISTANCE IN CLINICAL ISOLATES OF CAMPYLOBACTER-JEJUNI
    SEGRETI, J
    GOOTZ, TD
    GOODMAN, LJ
    PARKHURST, GW
    QUINN, JP
    MARTIN, BA
    TRENHOLME, GM
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04): : 667 - 670
  • [39] Clinical significance of high-level gentamicin resistance in enterococci causing bacteraemia
    Bilikova, E
    Gogova, M
    Svetlansky, I
    Lovaszova, M
    Kadlubjakova, E
    Pichnova, E
    Krcmery, V
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (06) : 525 - 526
  • [40] CONCOMITANT HIGH-LEVEL VANCOMYCIN AND PENICILLIN RESISTANCE IN CLINICAL ISOLATES OF ENTEROCOCCI
    HANDWERGER, S
    PERLMAN, DC
    ALTARAC, D
    MCAULIFFE, V
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (03) : 655 - 661